| Cancer stem cells CT Jordan, ML Guzman, M Noble New England Journal of Medicine 355 (12), 1253-1261, 2006 | 2126 | 2006 |
| The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells CT Jordan, D Upchurch, SJ Szilvassy, ML Guzman, DS Howard, ... Leukemia 14 (10), 1777-1784, 2000 | 1068 | 2000 |
| Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells ML Guzman, SJ Neering, D Upchurch, B Grimes, DS Howard, DA Rizzieri, ... Blood, The Journal of the American Society of Hematology 98 (8), 2301-2307, 2001 | 1017 | 2001 |
| The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells ML Guzman, RM Rossi, L Karnischky, X Li, DR Peterson, DS Howard, ... Blood 105 (11), 4163-4169, 2005 | 900 | 2005 |
| Preferential induction of apoptosis for primary human leukemic stem cells ML Guzman, CF Swiderski, DS Howard, BA Grimes, RM Rossi, ... Proceedings of the National Academy of Sciences 99 (25), 16220-16225, 2002 | 633 | 2002 |
| Somatic mutations precede acute myeloid leukemia years before diagnosis P Desai, N Mencia-Trinchant, O Savenkov, MS Simon, G Cheang, S Lee, ... Nature medicine 24 (7), 1015-1023, 2018 | 616 | 2018 |
| An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells ML Guzman, RM Rossi, S Neelakantan, X Li, CA Corbett, DC Hassane, ... Blood, The Journal of the American Society of Hematology 110 (13), 4427-4435, 2007 | 526 | 2007 |
| 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party M Heuser, SD Freeman, GJ Ossenkoppele, F Buccisano, CS Hourigan, ... Blood, The Journal of the American Society of Hematology 138 (26), 2753-2767, 2021 | 511 | 2021 |
| Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia S Li, FE Garrett-Bakelman, SS Chung, MA Sanders, T Hricik, F Rapaport, ... Nature medicine 22 (7), 792-799, 2016 | 415 | 2016 |
| Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo D Borkin, S He, H Miao, K Kempinska, J Pollock, J Chase, T Purohit, ... Cancer cell 27 (4), 589-602, 2015 | 386 | 2015 |
| Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90 K Moulick, JH Ahn, H Zong, A Rodina, L Cerchietti, EM Gomes DaGama, ... Nature chemical biology 7 (11), 818-826, 2011 | 306 | 2011 |
| The epichaperome is an integrated chaperome network that facilitates tumour survival A Rodina, T Wang, P Yan, EDG Gomes, MPS Dunphy, N Pillarsetty, ... Nature 538 (7625), 397-401, 2016 | 281 | 2016 |
| Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis I Topisirovic, ML Guzman, MJ McConnell, JD Licht, B Culjkovic, ... Molecular and cellular biology 23 (24), 8992-9002, 2003 | 263 | 2003 |
| FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels V Trujillo-Alonso, EC Pratt, H Zong, A Lara-Martinez, C Kaittanis, ... Nature nanotechnology 14 (6), 616-622, 2019 | 259 | 2019 |
| Iron and reactive oxygen species: friends or foes of cancer cells? LM Bystrom, ML Guzman, S Rivella Antioxidants & redox signaling 20 (12), 1917-1924, 2014 | 250 | 2014 |
| Evolution of acute myelogenous leukemia stem cell properties after treatment and progression TC Ho, M LaMere, BM Stevens, JM Ashton, JR Myers, KM O’Dwyer, ... Blood, The Journal of the American Society of Hematology 128 (13), 1671-1678, 2016 | 249 | 2016 |
| Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data DC Hassane, ML Guzman, C Corbett, X Li, R Abboud, F Young, ... Blood, The Journal of the American Society of Hematology 111 (12), 5654-5662, 2008 | 245 | 2008 |
| Single-cell RNA sequencing reveals a signature of sexual commitment in malaria parasites A Poran, C Nötzel, O Aly, N Mencia-Trinchant, CT Harris, ML Guzman, ... Nature 551 (7678), 95-99, 2017 | 242 | 2017 |
| The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target S Hewamana, S Alghazal, TT Lin, M Clement, C Jenkins, ML Guzman, ... Blood, The Journal of the American Society of Hematology 111 (9), 4681-4689, 2008 | 236 | 2008 |
| Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-κB inhibitor, DMAPT (LC-1) S Neelakantan, S Nasim, ML Guzman, CT Jordan, PA Crooks Bioorganic & medicinal chemistry letters 19 (15), 4346-4349, 2009 | 225 | 2009 |
